Venture Kick is a private philanthropic initiative based in Zurich, Switzerland, founded in 2007 to support Swiss startups at the pre-seed stage. It provides up to 150,000 Swiss francs in funding and offers structured entrepreneurial training aimed at developing sustainable businesses. Entrepreneurs participate in a competitive process, pitching their ideas up to three times for increasing funding amounts, while receiving valuable feedback from expert juries. To date, Venture Kick has supported 600 startup projects with a total of 24.9 million francs, leading to the incorporation of 454 active companies that have created over 6,000 jobs and attracted approximately 2.49 billion francs in subsequent investments. Companies founded by Venture Kick alumni have notably achieved significant recognition, with 55 percent of the TOP 100 Swiss Startup Award in 2018 represented by these ventures. In 2019, the initiative aimed to allocate 4.35 million francs to support idea-stage projects, facilitating the transition of Swiss scientific innovations to global markets.
JOSEPHA is an online service for consumers who want to quickly find the best prices for any product by comparing offers from multiple shops in one place.
Unomr
Grant in 2025
Unomr develops novel nano-micro technology based sensing approaches for diagnostics and drug discovery.
REMUUN
Grant in 2025
REMUUN strives to transform the biotech sector with its revolutionary MEGA therapeutic antibody development platform.
Clee Medical
Grant in 2025
Clee Medical believes the rapid growth of neurotech is constrained by inefficiencies in surgical tools and techniques.
Carewell
Grant in 2025
Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
Verretex
Grant in 2025
Verretex takes low-quality recycled glass fiber and employs proprietary technology to regenerate its qualities, resulting in high-quality glass fiber textiles that may be reused in new products.
CellX Biosolutions
Pre Seed Round in 2025
CellX Biosolutions is the Sustainable treatment of chemical waste.
Dphi Space
Pre Seed Round in 2025
DPhi Space is focused on creating ridesharing platforms to make space access more democratic and affordable. The company aims to streamline the deployment of small satellites by integrating multiple payloads and coordinating launch schedules with various providers. This approach reduces the costs and complexities typically associated with satellite launches, allowing researchers to optimize capacity utilization and decrease dependency on dedicated launches. As a result, DPhi Space facilitates faster and more cost-effective deployment of both software and hardware in orbit, contributing to the advancement of spacefaring infrastructure.
NovoViz
Grant in 2025
NovoViz develops and manufactures single-photon computational engines for applications at various technological nodes.
Mimic
Grant in 2025
Mimic specializes in developing and deploying advanced robotic systems to address global labor shortages. The company focuses on creating industrial robotic hands that facilitate gesture-based control and feature a simplified joint design, promoting cost efficiency. By leveraging a scalable foundational AI model, Mimic's robots are capable of dexterous manipulation, adapting through direct learning from human data. This innovative approach allows their solutions to integrate seamlessly into existing human workplaces, enhancing automation and improving operational efficiency.
Scanvio
Grant in 2025
Scanvio offers AI-augmented ultrasound software for faster endometriosis diagnosis, providing expert sonography skills to gynecologists, improving health and surgical education.
Lightium
Seed Round in 2025
Lightium AG is a Swiss startup that specializes in Photonic Integrated Circuits (PIC) foundry and design services, utilizing its proprietary Thin-Film Lithium Niobate (TFLN) platform. The company addresses the challenges faced by photonic device manufacturers by providing superior photonic performance, a streamlined supply chain, and the ability to scale from prototyping to large-scale production efficiently. As Europe's first production-grade TFLN foundry, Lightium supports the development of advanced photonic solutions across various sectors, including telecommunications, data communications, quantum computing, artificial intelligence, and space technology. Its focus on high-volume manufacturing and robust process flows positions Lightium as a key player in the evolution of photonic technologies.
Helix Robotics
Pre Seed Round in 2025
Helix Robotics is developing the first commercial soft robot manipulator, addressing the need for human-friendly and reliable robotics.
qCella
Pre Seed Round in 2025
qCella Impregnate natural fibers with copper and utilize them to create heating mats that outperform commercially available heating wires. When linked to a power source (e.g., a battery), the mats have the right electrical resistance over the entire structure, allowing them to heat uniformly.
Actival
Grant in 2024
Actival is driven by innovation and the integration of AI tools in dentistry. It is committed to precision and oral health.
Jaipur Robotics
Grant in 2024
Jaipur Robotics focuses on developing waste recycling ecosystem doliutions usng AI Algorithms.
Azure Cell Therapies
Grant in 2024
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
BLEEDnFIRE Therapeutics
Grant in 2024
BLEEDnFIRE is a pioneering innovator in siRNA-based therapies for hemophilia. Its mission is to transform patient care and enhance the quality of life through targeted, effective, and novel treatments
California Department of Real Estate
Grant in 2024
California Department of Real Estate focuses on protecting and advancing the public interest in real estate matters. It employs licensing, regulation, education, and enforcement.
Grensol Group
Grant in 2024
Grensol Group mission is to maximize the recycling of end-of-life wastge.
Shape Biopharmaceuticals
Grant in 2024
Shape Biopharmaceuticals is dedicated to developing immunotherapeutic drugs aimed at treating chronic diseases that currently have limited treatment options. The company utilizes advanced protein design and formulation technologies to create a new generation of immunotherapies that address unmet medical needs. By focusing on genetically driven conditions, Shape Biopharmaceuticals seeks to enhance patient outcomes and provide hope for individuals who lack effective therapeutic alternatives.
Nerai Bio
Seed Round in 2024
Nerai Bio operates as an AI-assisted CRISPR protein engineering platform.
Ionic Wind
Grant in 2024
Ionic wind technologies, which use an internationally patented concept, alter the way airflow is generated. Instead of conventional rotating machinery, we move air with electric fields.
CellX Biosolutions
Grant in 2024
CellX Biosolutions is the Sustainable treatment of chemical waste.
WasteFlow
Seed Round in 2024
WasteFlow is a learning-based vision system developed to analyze waste flow. Today, the low recycling rate can be explained by the low financial incentive to recycle. By identifying the type of waste, we can gain a better understanding of its value and optimize the recycling process. Unfortunately, current solutions are expensive and focused on the final sorting step. Due to data gaps throughout the cycle, they fail to provide a comprehensive understanding of the processes involved and their respective KPIs. Our affordable and user-friendly service is designed to be accessible to all actors in the recycling cycle. By empowering them with the necessary tools, we strive to increase sorted material's purity, maximize existing system performance, and enhance recycling energy efficiency.
Sentinus
Seed Round in 2024
Sentinus provides innovative technologies that automate manual assembly operations by incorporating deep-learning-based quality assurance systems.
Optiverse
Grant in 2024
Optiverse enables firms to access knowledge from several sessions and automate follow-up tasks. Optiverse assists customers in automating the most unpleasant processes associated with meetings.
RTDT Laboratories
Grant in 2024
RTDT is a No-code SaaS for Structural Health Monitoring of wind turbines.
Lighthouse Tech
Grant in 2024
Lighthouse Tech specializes in designing smart eyewear frames aimed at individuals with vision impairment, blindness, and spatial perceptual disorders. Their innovative product detects obstacles above the waist and alerts users through soft haptic vibrations. The eyewear is crafted to resemble conventional frames or sunglasses, ensuring that users do not compromise on style while benefiting from enhanced safety and mobility. By combining functionality with fashion, Lighthouse Tech promotes independent outdoor navigation, ultimately fostering a greater sense of self-sufficiency and well-being for its customers.
Translation-X
Pre Seed Round in 2024
Translation-X is a spin-off project that develops novel therapeutics for Autism spectrum disorders.
ValTech Lifesciences
Grant in 2024
ValTech Lifesciences is a medtech startup promoting cardiovascular health through its proprietary heart valve characteristics that improve the performance of mechanical and biological prostheses.
Hoshii
Grant in 2024
Hoshii unifies all B2B wholesaler correspondence into a solitary chat interface driven by artificial intelligence.
Perovskia
Seed Round in 2024
Perovskia specializes in the digital printing of custom solar cells utilizing patent-protected technology. The company operates at the convergence of printed electronics, photovoltaics, and material science, providing innovative solar cells designed to power various electronic devices. These solar cells can be printed directly onto glass and other substrates, presenting significant advantages over conventional silicon-based alternatives. This unique approach allows electronics manufacturers to enhance battery life and deliver sustainable power solutions, thereby contributing to the advancement of renewable energy in electronic applications.
Abrinca Genomics
Seed Round in 2024
Abrinca Genomics operates as a biotechnology company.
Deegtal
Grant in 2024
dEEGtal’s use of AI to expedite epilepsy diagnosis could make a significant difference in patient care, by analyzing EEG data quickly, it might help identify patterns or anomalies that could be missed by human reviewers alone.
Flink Robotics
Seed Round in 2024
Flink Robotics is a robotics engineering company.
Amporin Pharmaceuticals
Grant in 2024
Amporin Pharmaceuticals seeks to create a new class of small-molecule medications that block and eradicate harmful soluble oligomers and holes found within cell membranes.
Regenosca
Pre Seed Round in 2024
Regenosca SA is a Swiss company based in Lausanne that specializes in the development and commercialization of medical implants designed for bladder reconstruction. Founded in 2019, the company offers sterile, off-the-shelf implants that serve as alternatives to autologous tissue substitutes for soft tissue repair. These innovative biomaterials aim to enhance bladder preservation and minimize scarring, ultimately improving patients' quality of life. By focusing on easy-to-use medical devices, Regenosca is committed to advancing surgical practices and patient outcomes in bladder-related procedures.
TrueYouOmics
Convertible Note in 2024
The most comprehensive blood test, via multi-omics and AI, for disease risk identification and prevention planning.
SurroundPower
Grant in 2024
SurroundPower delivers a new approach with variability, an attractive design, and a higher safety standard than the existing power socket.
DemoSquare
Grant in 2024
DemoSquare is a pioneer in the realm of public-affairs management connect businesses with government affairs by putting regulatory monitoring on autopilot.
8links
Pre Seed Round in 2024
8links offers a multi-layer coating technique for scalable lithium-ion battery manufacture.
8links
Pre Seed Round in 2024
8links offers a multi-layer coating technique for scalable lithium-ion battery manufacture.
MindMetrix
Pre Seed Round in 2024
MindMetrix is a company that specializes in mental training through its innovative eye-tracking-based neurofeedback technology. This platform connects neurophysiology with virtual reality to enhance mental resilience training. By measuring quantifiable physiological parameters, MindMetrix assesses and monitors training improvements over time, helping athletes achieve peak performance more efficiently. The focus on combining advanced technology with mental training positions MindMetrix as a leader in the field of sports performance enhancement.
Isospec Analytics
Pre Seed Round in 2024
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are unlocking the potential of glycomics and metabolomics in disease biomarker discovery and for the development of safer nutritional and pharmaceutical products.
Kidemis
Grant in 2024
Kidemis develops innovative aquafeed solutions aimed at enhancing the sustainability of the aquaculture industry. The company produces mycoprotein, a sustainable alternative to fishmeal and fish oil, by utilizing mycelium-based fermentation to convert industrial food waste into low-processed protein. This process not only addresses the global undersupply of nutrition but also mitigates the environmental impact of aquaculture by reducing food waste. Kidemis's products offer clients eco-friendly and cost-effective alternatives to traditional protein sources, making them suitable for a range of meat replacement and vegan nutrition applications.
Dphi Space
Pre Seed Round in 2024
DPhi Space is focused on creating ridesharing platforms to make space access more democratic and affordable. The company aims to streamline the deployment of small satellites by integrating multiple payloads and coordinating launch schedules with various providers. This approach reduces the costs and complexities typically associated with satellite launches, allowing researchers to optimize capacity utilization and decrease dependency on dedicated launches. As a result, DPhi Space facilitates faster and more cost-effective deployment of both software and hardware in orbit, contributing to the advancement of spacefaring infrastructure.
Pace Locator
Grant in 2024
Pace Locator's aim is to leverage the potential of common, noninvasive patient data to enable faster, more reliable diagnosis and, eventually, safer, more successful treatment.
NovoViz
Grant in 2024
NovoViz develops and manufactures single-photon computational engines for applications at various technological nodes.
Procavea Biotech
Grant in 2023
Procavea Biotech specializes in developing a drug delivery platform centered on non-viral protein cages. This innovative platform is tailored for veterinary professionals, aiming to streamline and improve the efficiency of veterinary practice management. By providing a comprehensive solution, Procavea Biotech enhances overall operational effectiveness, enabling veterinary services to be delivered more seamlessly and integrated. Through its advancements, the company seeks to elevate the quality of care in veterinary practices.
AskEarth
Grant in 2023
AskEarth is a geospatial intelligence platform that delivers real-time and accurate geospatial information to help users predict future environmental changes. Originating as a spin-off from the University of Zurich, ETH, and EPFL, AskEarth specializes in providing unique insights derived from daily satellite images. Its platform includes features that comply with the EU Deforestation Regulation, offering tools for exposure assessment, automatic deforestation monitoring, and reporting. Users can monitor various environmental phenomena, such as coastline changes, deforestation, glacier melting, and transportation patterns. Additionally, the platform serves as an accessible resource for verifying news articles and obtaining essential earth observation data, enabling clients to explore and understand the planet effortlessly.
Planeto
Grant in 2023
Planeto is an energy transition company that specializes in providing energy planning software solutions aimed at decarbonizing the heating energy supply in buildings. The company develops energy efficiency software that facilitates the creation of district heating and cooling networks, connecting buildings to renewable energy sources. This approach enables clients to achieve a sustainable and clean environment, contributing to broader efforts in the energy transition.
RefFIT
Grant in 2023
RefFIT provides software for spectroscopic data analysis in material science, allowing users to use the tool without requiring expert training. This saves time and money in data analysis and model development for the company's growing user base.
Orio Therapeutics
Convertible Note in 2023
Orio Therapeutics is redefining regeneration by modifying therapeutic proteins to optimize distribution through controlled localization.
Chiral
Grant in 2023
Next-generation electronics with nanomaterials
Ascento
Grant in 2023
Ascento Robotics focuses on developing wheeled bipedal robotic systems designed for practical applications in outdoor security. By integrating the agility of legs with the efficiency of wheels, the company's robots can navigate obstacles such as stairs while providing quick and energy-efficient movement. Their robotics-as-a-service platform enhances outdoor security patrolling, allowing professionals to secure and inspect assets more effectively. This innovative approach not only reduces intervention times but also improves data collection capabilities, making it suitable for various real-world scenarios.
HeroSupport
Grant in 2023
HeroSupport is a medical device manufacturing company based in Veyrier, Geneva, established in 2019. The company specializes in creating personalized solutions that transform imaging and treatment tables into medical immobilization devices designed to enhance patient comfort during clinical procedures. By providing tailored support, these devices allow patients to receive prone breast radiotherapy without the need to adapt to the standard table setup. This innovation not only improves patient comfort but also aims to enhance the effectiveness and cost efficiency of cancer treatment for healthcare providers.
Tethys Robotics
Grant in 2023
Tethys Robotics specializes in the development of AI-powered robotic systems designed for underwater applications. The company focuses on creating innovative underwater robots that can perform various tasks in challenging environments, including search and recovery operations, inspections, mapping, and exploration. Their products emphasize modularity and feature advanced omnidirectional control, enabling professionals to collect and process data effectively. Tethys Robotics aims to enhance the safety, reliability, and efficiency of underwater operations for its users.
qCella
Grant in 2023
qCella Impregnate natural fibers with copper and utilize them to create heating mats that outperform commercially available heating wires. When linked to a power source (e.g., a battery), the mats have the right electrical resistance over the entire structure, allowing them to heat uniformly.
csky.ai
Pre Seed Round in 2023
csky.ai specializes in enhancing confidential conversations through its innovative Edge AI technology. The company has developed a microphone that processes and improves the clarity of sensitive discussions while maintaining privacy. By utilizing edge artificial intelligence, csky.ai's technology processes data locally on the device, which ensures that conversations remain confidential and eliminates the reliance on cloud storage. This approach allows organizations to generate secure, structured, and compliant transcripts from their meetings, effectively transforming sensitive conversations into organized documents.
Orio Therapeutics
Convertible Note in 2023
Orio Therapeutics is redefining regeneration by modifying therapeutic proteins to optimize distribution through controlled localization.
Inverto
Grant in 2023
Inverto's goal is to automate mangrove restoration as a service for mangrove restoration organizations. Mangroves are much better carbon sinks than terrestrial forests and are essential for biodiversity.
TALPA Inspection
Grant in 2023
TALPA Inspection provides electrochemical techniques for detecting corrosion damage in reinforced concrete subsurfaces.
Transpire Bio
Grant in 2023
Transpire Bio is a biotechnology platform focused on the development of inhaled therapeutics aimed at improving global health. The company specializes in creating lower-cost generic alternatives for injectable drugs, enhancing patient access to essential medications. Its portfolio includes medicines and inhalation therapies designed for treating lung diseases as well as systemic conditions, utilizing a painless delivery method to improve patient experience and adherence to treatment. Through its innovative approach, Transpire Bio seeks to make significant advancements in the field of inhalation therapies.
Cotierra
Grant in 2023
Terra Preta is a platform for decentralized biochar production that removes carbon and restores soil health.
plasNifix
Grant in 2023
PlasNifix has created a plasma aided nitrogen fixation process that allows for the sole use of green energy while producing ammonia (and other simple nitrogen-containing compounds) at lower temperatures and with substantially less energy.
AlpineWell
Grant in 2023
AlpineWell developing novel solutions to hunger and swallowing difficulties, AlpineWell produces patient-centric food for special medicinal purposes (FSMP) and also provides automatic nutrition tracking to detect malnutrition early on.
Gaia Tech
Pre Seed Round in 2023
Gaia Technologies specializes in upcycling agricultural sidestreams, particularly olive waste, into valuable bio-compounds and ingredients for the cosmetics, food, and feed industries. By employing a modular and scalable extraction process, Gaia addresses the growing demand for natural alternatives to synthetic compounds while helping primary sector firms create new value streams and minimize their environmental impact. The company's innovative approach is built on insights from the EIT Food project Phenoliva, enabling the commercialization of products such as antioxidants, biochar, activated carbon, and biogas. This technology not only supports a circular economic model within food production but also positions Gaia as a cost-effective solution provider in the agro-based technology sector.
CompagOs
Convertible Note in 2023
CompagOs is focused on enhancing cancer treatment for patients with bone cancer through an innovative in vitro diagnostic tool. Utilizing advanced 3D bioprinting technology, the company creates mineralized bone organoids that replicate the unique cancerous conditions of individual patients within a controlled laboratory environment. This allows for the assessment of drug reactions in a complex bone microenvironment, surpassing the limitations of traditional animal and 2D models. The platform not only aims to personalize treatment options for patients but also serves as a valuable research tool for clinical, pharmaceutical, and biotech sectors. By enabling researchers to evaluate drug efficacy in a realistic and patient-relevant context, CompagOs is positioned to drive advancements in oncology and improve patient outcomes.
Isospec Analytics
Grant in 2023
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are unlocking the potential of glycomics and metabolomics in disease biomarker discovery and for the development of safer nutritional and pharmaceutical products.
CERN
Grant in 2023
CERN is a prominent particle-physics laboratory located in Geneva, Switzerland, established in 1954. It serves as the European organization for nuclear research, where physicists and engineers investigate the fundamental structure of the universe. CERN specializes in providing advanced particle accelerators and detectors, which are essential for high-energy physics research. These accelerators propel beams of particles to high energies, enabling collisions that are then analyzed by sophisticated detectors to explore the basic constituents of matter and the forces between them. Governed by 22 member states, CERN represents a significant collaborative effort in scientific research, focusing on the fundamental questions of physics and contributing to the global understanding of the universe.
a-metal
Grant in 2023
A-metal is a manufacturer of three-dimensional (3D) printers focused on making metal additive manufacturing accessible to a wide range of organizations. The company offers an affordable, compact, and safe laser powder bed fusion (LPBF) machine that features a unique cartridge system for secure powder handling, eliminating the need for a laboratory environment. This innovation allows small and medium enterprises, as well as small research and development departments, to produce small quantities of metal parts for prototypes, testing, and limited production runs. By enhancing accessibility to metal 3D printing, A-metal aims to boost innovation and sustainability within the economy.
Apheros
Grant in 2023
Apheros is a company specializing in metal foam cooling solutions, focusing on innovative manufacturing methods for metal foams that exhibit unique cooling properties. It offers a diverse range of materials, including iron, stainless steel, copper, and nickel, while ensuring that these materials maintain their thermal and electrical conductivity as well as mechanical stability. Apheros aims to support a variety of applications, including cooling, lubrication, and catalysis, particularly in the context of battery materials. Its patent-pending manufacturing approach allows for scalability, enabling clients to develop advanced products that leverage the benefits of metal foam technology.
irmos
Grant in 2023
Irmos Technologies is a start-up focused on enhancing the repair and preservation of bridges and buildings through real-time, AI-powered structural condition evaluation. The company has developed a data-driven platform for structural health monitoring, designed to maximize the safe operational life of existing infrastructure. This innovative software solution enables engineers to monitor the structural health of real structures in real time, allowing customers to reduce maintenance costs, extend the lifespan of assets, and improve public safety. Through its advanced technology, Irmos aims to transform the approach to maintaining critical infrastructure.
Neology Hydrogen
Convertible Note in 2023
Neology’s ammonia-powered genset represents the next generation of clean power solutions. This advanced system delivers reliable energy with zero emissions, operating completely carbon-free. Designed to be mobile and versatile, it is perfect for off-grid and remote applications. Additionally, its silent operation ensures minimal noise pollution, making it an ideal choice for sustainable and efficient energy generation in any environment.
ASTRA Therapeutics
Grant in 2023
ASTRA Therapeutics is a medication development business that uses cutting-edge science and technology to discover new therapeutic treatment candidates for the full spectrum of parasite disorders.
Vamoz
Convertible Note in 2023
Vamoz is a Swiss-based SaaS solution enabling companies to make remote work abroad an official benefit for their employees. Whether that means to work from the beach in Mexico or from a relative's house by the sea. Our vision is to inspire and facilitate those reimagining traditional work-life. Giving employees the opportunity to work temporarily from anywhere, and companies the chance to attract and retain top talent without facing uncontrollable legal and business risks. Vamoz!
metaLead Therapeutics
Grant in 2023
metaLead Therapeutics is focused on developing a novel peptide medication aimed at transforming the treatment of metal-related diseases, particularly lead poisoning. The company’s innovative approach involves a peptide that selectively binds to lead ions while preserving essential metal ions. This specificity ensures the medication remains highly stable and effective, allowing for administration through both oral and intravenous routes. By targeting lead poisoning, metaLead Therapeutics aims to provide a significant improvement in detoxification methods for individuals affected by this condition worldwide.
Tandem Therapeutics
Grant in 2023
Tandem Therapeutics develops peptide therapeutics that target and treat the extracellular matrix barrier.
Adularia
Grant in 2023
Adularia is a microbial-based therapy for Colorectal cancer.
Rapidata
Convertible Note in 2023
Rapidata is a data processing platform that specializes in human-verified data labeling and processing services. It provides innovative technology designed to handle large volumes of data by integrating human intelligence and sentiment analysis tailored to specific regions. The platform allows customers to create customized tasks, facilitating rapid scaling and cost-effective labeling of extensive datasets. This enables clients to efficiently access tools for both labeling and validating their data, making Rapidata a valuable resource for organizations requiring precise and expansive data processing capabilities.
Correntics
Pre Seed Round in 2023
Correntics operates a climate risk assessment platform aimed at enhancing the resilience of global supply chains. By employing a data-driven approach, the company provides clients with a comprehensive overview of their supply chains, from raw material availability to final delivery. Its platform utilizes real-time hazard and probabilistic risk modeling to generate forward-looking scenarios, enabling clients to gain actionable insights that help mitigate potential disruptions. Correntics' expertise supports businesses in reducing risks associated with climate change and other emerging threats, ultimately fostering improved operational efficiency and financial stability while ensuring sustainability in their activities.
Optiml
Grant in 2022
Optiml specializes in real estate investment and renovation planning by providing a digital solution that empowers asset management to achieve sustainability goals while maintaining profitability. The software analyzes critical building data, including energy consumption and occupancy patterns, to identify improvement areas. It automates adjustments to building systems, such as heating and lighting, to minimize energy waste without compromising occupant comfort. By offering AI-powered workflows, Optiml helps real estate professionals understand their current asset status, optimize investment strategies, and plan targeted renovation actions. The company's scalable software addresses challenges like inadequate data and manual workflows, enabling users to adapt to changing regulatory and market conditions for long-term compliance.
Rhovica Neuroimaging
Grant in 2022
Rhovica Neuroimaging is a rapid and safe placement of an external ventricular drain (EVD) and is a lifesaving emergency procedure. EVDs are thin catheters, that are inserted into the brain cavities (ventricles) for fluid drainage to decrease intracranial pressure (ICP) and for measurement of ICP.
Evoly
Grant in 2022
Evoly specializes in transforming traditional energy meters into smart devices at a significantly reduced cost. The company offers a comprehensive technology solution that assists energy providers in accessing and analyzing their customers' consumption data for both electricity and water. By combining software and hardware components, Evoly's platform facilitates real-time insights into the electric grid and supports various services such as gateway management and live data tracking. This allows energy providers to automate essential tasks, including fraud detection, remote reading, automatic billing, and dynamic pricing. Through its innovative approach, Evoly enhances operational efficiency for energy providers while improving customer engagement.
Simon & Joseph
Grant in 2022
Simon & Josef specializes in providing a personalized room service system for the hospitality industry, enabling hotels to enhance guest experiences while promoting environmental sustainability. Their innovative solution allows guests who stay two nights or more to customize their room cleaning preferences, ensuring that resources such as water, electricity, and cleaning products are used efficiently. By allowing guests to request services only when necessary, the company helps hotels reduce operational costs and minimize their environmental impact. This approach not only caters to the individual needs of guests but also supports hoteliers in their efforts to operate in a more sustainable manner.
WattAnyWhere
Grant in 2022
WattAnyWhere is focused on revolutionizing the delivery of high-power electricity by providing clean, renewable energy solutions. The company has developed a mobile generator that utilizes renewable ethanol sourced from biomass to generate electricity. This innovative approach allows for fast-charging services for battery electric vehicles, making it possible to establish charging points in remote locations. By shifting away from fossil fuels and centralized power structures, WattAnyWhere aims to offer adaptable, customer-centric solutions that not only meet high electricity demands but also contribute to environmental sustainability by reducing greenhouse gas emissions.
Ocumeda
Grant in 2022
Ocumeda is a telemedical network specializing in ophthalmology, providing accessible eye examinations through collaborations with opticians, retirement homes, and various companies. The company's services include remote assessments conducted by board-certified ophthalmologists, utilizing a secure cloud platform and advanced medical artificial intelligence to enhance the screening process. This approach aims to enable opticians and pharmacies to effectively detect blindness and prevent vision loss, ensuring that individuals receive timely and accurate eye care.
Splint Invest
Grant in 2022
Splint Invest is a financial services company that operates a marketplace for retail investors seeking access to alternative investments. The company provides a platform where pre-selected issuers can offer their investment products, allowing private investors to engage in fractional investments. Utilizing advanced technologies, such as distributed ledger technology and artificial intelligence, Splint Invest streamlines the investment process by handling legal requirements, tokenization, custody, data management, and cash management. This innovative approach enables investors to diversify their portfolios and access a range of previously unserved investment opportunities.
Aukera Therapeutics
Grant in 2022
Aukera Therapeutics is a biotechnology company focused on developing innovative therapeutics for patients affected by diseases related to the mTOR protein, including cancer and neurodegenerative disorders. Originating as a spin-off from the Biozentrum of the University of Basel, Aukera Therapeutics has established a pharmaceutical drug discovery engine that creates selective inhibitors of the mTOR complex. This technology aims to target various branches of the mTOR pathway, facilitating the development of treatments that not only address cancer but also manage the overactivity of the mTORC1 complex, which is crucial for regulating cell growth. Through its research and development efforts, Aukera Therapeutics strives to provide effective therapeutic options for patients with these challenging conditions.
Correntics
Grant in 2022
Correntics operates a climate risk assessment platform aimed at enhancing the resilience of global supply chains. By employing a data-driven approach, the company provides clients with a comprehensive overview of their supply chains, from raw material availability to final delivery. Its platform utilizes real-time hazard and probabilistic risk modeling to generate forward-looking scenarios, enabling clients to gain actionable insights that help mitigate potential disruptions. Correntics' expertise supports businesses in reducing risks associated with climate change and other emerging threats, ultimately fostering improved operational efficiency and financial stability while ensuring sustainability in their activities.
Rapidata
Convertible Note in 2022
Rapidata is a data processing platform that specializes in human-verified data labeling and processing services. It provides innovative technology designed to handle large volumes of data by integrating human intelligence and sentiment analysis tailored to specific regions. The platform allows customers to create customized tasks, facilitating rapid scaling and cost-effective labeling of extensive datasets. This enables clients to efficiently access tools for both labeling and validating their data, making Rapidata a valuable resource for organizations requiring precise and expansive data processing capabilities.
Vamoz
Convertible Note in 2022
Vamoz is a Swiss-based SaaS solution enabling companies to make remote work abroad an official benefit for their employees. Whether that means to work from the beach in Mexico or from a relative's house by the sea. Our vision is to inspire and facilitate those reimagining traditional work-life. Giving employees the opportunity to work temporarily from anywhere, and companies the chance to attract and retain top talent without facing uncontrollable legal and business risks. Vamoz!
matriq
Seed Round in 2022
Matriq AG is a machinery manufacturing company based in St. Gallenkappel, Switzerland, specializing in automated solutions for the individual marking of plastic components. Founded in 2019, the company has developed a patented technology known as DynamicMold, which allows for the direct marking of plastic parts during the manufacturing process, including methods such as injection molding, blow molding, and thermoforming. This technology provides product manufacturers with capabilities for traceability and brand protection by embedding unique, forgery-proof codes into each plastic product.
Biosimo Chemicals
Pre Seed Round in 2022
Biosimo is a chemical engineering start-up focused on producing bio-based platform chemicals through innovative processes. The company aims to develop sustainable chemicals by utilizing advanced catalytic reactions and purification techniques. Its flagship technology replaces traditional production methods of acetic acid, which typically rely on coal and gas, with a novel approach that uses ethanol derived from biomass and waste. This shift not only supports the chemical, pharmaceutical, and material industries but also provides a direct alternative to fossil-based resources, promoting a more sustainable chemical production landscape.
Sensawear
Grant in 2022
Sensawear provides sensors for postoperative monitoring and preventing pressure injuries.
SightIn Health
Grant in 2022
SightIn Health is a Swiss company founded in 2021 that specializes in artificial intelligence-powered software for portable ultrasound devices. The firm has developed an imaging platform that enhances the functionality of ultrasound machines by providing automated quality assessments, probe guidance, and image analysis. This technology aims to reduce the skill barrier traditionally associated with ultrasound equipment, making it easier for healthcare providers to capture and interpret medical images. By improving the accuracy of medical diagnostics and prognostics, SightIn Health supports healthcare companies in delivering better patient care.
Synature
Grant in 2022
Synature is an early-stage Swiss startup. The aim of Synature is to make biodiversity measurable to quantify the heartbeat of ecosystems. The startup based at the EPFL Innovation Park aims to achieve this goal by leveraging bioacoustics. This involves recording the sounds of nature and using AI and signal processing to analyse the gathered data. Synature has a holistic offering including automated and autonomous recorders that send audio recordings from the field, automated analysis of the gathered data and a dashboard that displays the data in an easy-to-understand way.
Maven Health
Non Equity Assistance in 2022
Maven Health is a health tech company that provides an end-to-end metabolic health solution designed for healthcare providers. It specializes in assessing individuals' metabolic health using saliva as the bio-fluid for metabolite measurements. These measurements are analyzed with advanced Nuclear Magnetic Resonance (NMR) spectrometers employing custom analytical methods. The system is designed to be minimally invasive and cost-effective, assisting healthcare professionals in identifying at-risk individuals who may not be recognized through traditional healthcare practices. The results are delivered through an intuitive data platform, facilitating better decision-making and patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.